CytomX Therapeutics, Inc. Gains 129.43%
Mon, May 12, 2025 at 07:37 PM
CytomX Therapeutics, Inc. (CTMX:NASDAQ) shot up at $2.13, a gain of 129.4%. On Mon, May 12, 2025, CTMX:NASDAQ hit a New 2-Week High of $2.13. The stock appeared on our News Catalysts scanner on Mon, May 12, 2025 at 11:15 AM in the 'BIOTECH' category. From Mon, Apr 28, 2025, the stock recorded 60.00% Up Days and 54.55% Green Days
About CytomX Therapeutics, Inc. (CTMX:NASDAQ)
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is engaged in developing antibody therapeutics based on probody technology platform.
Top 10 Gainers:
- DevvStream Corp. (DEVS:NASDAQ), 290.93%
- Kindly MD, Inc. (KDLY:NASDAQ), 251.03%
- Gryphon Digital Mining, Inc. (GRYP:NASDAQ), 173.08%
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 129.43%
- Hempacco Co., Inc. (HPCO:NASDAQ), 87.5%
- Taoping Inc. (TAOP:NASDAQ), 80.21%
- Jayud Global Logistics Limited (JYD:NASDAQ), 67.71%
- Top Win International Limited (TOPW:NASDAQ), 56.25%
- Foremost Clean Energy Ltd. (FMST:NASDAQ), 50.94%
- Funko, Inc. (FNKO:NASDAQ), 46.44%